CAMBRIDGE, Mass. (AP) _ Idera Pharmaceuticals Inc. (IDRA) on Monday reported a loss of $21.5 million in its second quarter.
The Cambridge, Massachusetts-based company said it had a loss of 14 cents per share.
The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 11 cents per share.
The drugmaker posted revenue of $187,000 in the period.
In the final minutes of trading on Monday, the company's shares hit $1.83. A year ago, they were trading at $1.89.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IDRA at https://www.zacks.com/ap/IDRA
Keywords: Idera Pharmaceuticals, Earnings Report